TCRYPTION

TCRyption is a preclinical company focused on the development of novel approaches to TCR based cellular therapy for cancer and other indications. TCRyption seeks to develop a pipeline of product candidates that can treat cancer type and patient populations that are underserved by current approaches.

#Financial #More

TCRYPTION

Industry:
Biotechnology Health Care

Founded:
2020-10-01

Address:
New York, New York, United States

Country:
United States

Status:
Active

Total Funding:
10 M USD


Investors List

tio-bioventures_image

TIO Bioventures

TIO Bioventures investment in Seed Round - TCRyption

More informations about "TCRyption" on Search Engine